BiotechTube
Home/Matinas Biopharma/Evelyn D’An
ED

Evelyn D’An

Member, Board of Directors; Audit Committee Chair

Matinas Biopharma

Therapeutic Areas

Infectious DiseaseOncologyInflammation

Matinas Biopharma Pipeline

DrugIndicationPhase
MAT2203Invasive Candidiasis and AspergillosisPhase 2
LNC Platform (siRNA/ASO delivery)Inflammation (implied from research)Preclinical

Leadership Team at Matinas Biopharma

JD
Jerome D. Jabbour
Chief Executive Officer
KM
Keith Murphy
Independent Member, Board of Directors; Chair of Nominating and Governance Committee
EN
Edward Neugeboren
Independent Member, Board of Directors; Chair of Compensation Committee
DR
Dr. Robin L. Smith
Member, Board of Directors
MW
Matthew Wikler
Former Board Member
NG
Natasha Giordano
Former Board Member
View full Matinas Biopharma profile